Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...
Apollo Hospitals in Hyderabad becomes India's first AHA-certified comprehensive stroke centre: Our Bureau, Chennai Tuesday, March 25, 2025, 17:15 Hrs [IST] Apollo Hospitals in Hyd ...
CStone Pharma seeks EMA approval for sugemalimab to treat patients with unresectable stage III non-small cell lung cancer: Suzhou, China Tuesday, March 25, 2025, 17:00 Hrs [IST] C ...
Clover Biopharma receives IND clearance from US FDA and begins revaccination clinical study for RSV vaccine candidate SCB-1019: Shanghai Tuesday, March 25, 2025, 16:00 Hrs [IST] C ...
US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...
Clearmind Medicine’s US FDA approved clinical trial for CMND-100 moves forward as drug arrives in United States: Vancouver, Canada Tuesday, March 25, 2025, 13:00 Hrs [IST] Clear ...
Silexion Therapeutics completes development plan for next-generation siRNA candidate SIL204; plans to present at 2025 NeauxCancer Conference: Grand Cayman, Cayman Islands Tuesday, ...
NHAI and Amrita Hospital’s emergency training designed to avert road fatalities if care if given within Golden Hour: Our Bureau, Bengaluru Tuesday, March 25, 2025, 13:45 Hrs [IS ...
Our Bureau, Bengaluru Tuesday, March 25, 2025, 12:15 Hrs [IST] ...
Rapport Therapeutics to showcase data at 2025 American Academy of Neurology Annual Meeting in San Diego from April 5-9, 2025: San Diego Tuesday, March 25, 2025, 14:00 Hrs [IST] Ra ...
Health Technology Assessment by IIPHG noted qXR by Qure.ai as financially prudent in early detection of TB: Our Bureau, Bengaluru Tuesday, March 25, 2025, 11:30 Hrs [IST] The new ...
Harbour BioMed inks collaboration with AstraZeneca to discover and develop next-generation therapeutic antibodies: Shanghai & Rotterdam, The Netherlands Tuesday, March 25, 2025, 1 ...